Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial

V.M.J. Verhoef; R.P. Bosgraaf; F.J. van Kemenade; L. Rozendaal; D.A.M. Heideman; A.T. Hesselink; R.L.M. Bekkers; R.D.M. Steenbergen; L.F.A.G. Massuger; W.J.G. Melchers; J. Bulten; L.I.H. Overbeek; J. Berkhof; P.J.F. Snijders; C.J.L.M. Meijer

doi:10.1016/S1470-2045(14)70019-1

Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial

V.M.J. Verhoef, R.P. Bosgraaf, F.J. van Kemenade, L. Rozendaal, D.A.M. Heideman, A.T. Hesselink, R.L.M. Bekkers, R.D.M. Steenbergen, L.F.A.G. Massuger, W.J.G. Melchers, J. Bulten, L.I.H. Overbeek, J. Berkhof, P.J.F. Snijders, C.J.L.M. Meijer

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	315-322
Journal	Lancet Oncology
Volume	15
Issue number	3
DOIs	https://doi.org/10.1016/S1470-2045(14)70019-1
Publication status	Published - 2014

Access to Document

10.1016/S1470-2045(14)70019-1

Cite this

Verhoef, V. M. J., Bosgraaf, R. P., van Kemenade, F. J., Rozendaal, L., Heideman, D. A. M., Hesselink, A. T., Bekkers, R. L. M., Steenbergen, R. D. M., Massuger, L. F. A. G., Melchers, W. J. G., Bulten, J., Overbeek, L. I. H., Berkhof, J., Snijders, P. J. F., & Meijer, C. J. L. M. (2014). Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. Lancet Oncology, 15(3), 315-322. https://doi.org/10.1016/S1470-2045(14)70019-1

@article{03fcd04346bb4fa18a0b7b99874227fc,

title = "Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial",

author = "V.M.J. Verhoef and R.P. Bosgraaf and {van Kemenade}, F.J. and L. Rozendaal and D.A.M. Heideman and A.T. Hesselink and R.L.M. Bekkers and R.D.M. Steenbergen and L.F.A.G. Massuger and W.J.G. Melchers and J. Bulten and L.I.H. Overbeek and J. Berkhof and P.J.F. Snijders and C.J.L.M. Meijer",

year = "2014",

doi = "10.1016/S1470-2045(14)70019-1",

language = "Undefined/Unknown",

volume = "15",

pages = "315--322",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "3",

}

Verhoef, VMJ, Bosgraaf, RP, van Kemenade, FJ, Rozendaal, L, Heideman, DAM, Hesselink, AT, Bekkers, RLM, Steenbergen, RDM, Massuger, LFAG, Melchers, WJG, Bulten, J, Overbeek, LIH, Berkhof, J, Snijders, PJF & Meijer, CJLM 2014, 'Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial', Lancet Oncology, vol. 15, no. 3, pp. 315-322. https://doi.org/10.1016/S1470-2045(14)70019-1

Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. / Verhoef, V.M.J.; Bosgraaf, R.P.; van Kemenade, F.J. et al.

In: Lancet Oncology, Vol. 15, No. 3, 2014, p. 315-322.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial

AU - Verhoef, V.M.J.

AU - Bosgraaf, R.P.

AU - van Kemenade, F.J.

AU - Rozendaal, L.

AU - Heideman, D.A.M.

AU - Hesselink, A.T.

AU - Bekkers, R.L.M.

AU - Steenbergen, R.D.M.

AU - Massuger, L.F.A.G.

AU - Melchers, W.J.G.

AU - Bulten, J.

AU - Overbeek, L.I.H.

AU - Berkhof, J.

AU - Snijders, P.J.F.

AU - Meijer, C.J.L.M.

PY - 2014

Y1 - 2014

U2 - 10.1016/S1470-2045(14)70019-1

DO - 10.1016/S1470-2045(14)70019-1

M3 - Article

VL - 15

SP - 315

EP - 322

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 3

ER -